Pay in 4 interest-free payments of $5.42 Learn more
Ships within 48 hours · Estimated delivery Oct 28 - Nov 2
Starting in January 2025, Ozempic gained FDA approval for reducing kidney disease risks in adults with type 2 diabetes who also have chronic kidney disease
As of January 1, 2025, Kaiser California removed GLP-1 (a class of weight loss medications) coverage from base plans for members with BMI (body mass index) under 40
If you're still hungry on Ozempic, ask yourself a few questions
You have at least one weight-related condition (hypertension, type 2 diabetes, or high cholesterol)
As the system isnt audited or verified, individuals can submit duplicate reports, meaning the numbers could be inflated
US$ 25.56
US$ 23.42
US$ 27.12
